Dr. Hongtao Li 李鸿涛
Chief Physician
Head and Neck Surgery, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionDr. Li is a Chief Physician, Associate Professor, and Master's supervisor. Dr. Li graduated from Xinjiang Medical University in 2000, earned a master's degree in 2009, and completed a three-month fellowship at Kitasato University School of Medicine in Tokyo, Japan, from August to November 2012.
Name order: in Chinese the family name comes first (Li Hongtao). Papers usually list the name as Hongtao Li or Li H.
Selected publications
25 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): Spatial organization of the TNBC tumor microenvironment: multicellular niches, T-cell bottlenecks, and therapeutic opportunities. PubMed 42443980
- Sci Rep, 2026 (senior author): Integrative single-cell and spatial transcriptomics with machine learning identify a Luminal-inflam malignant program and reveal an RPN1-PERK UPR vulnerability in triple-negative breast cancer. PubMed 42270806
- Front Oncol, 2026 (senior author): Prognostic prediction model for triple-negative breast cancer using artificial intelligence and ultrasound radiomics. PubMed 41815549
- Arch Med Sci, 2025 (first author): Exosomal miR-182-5p from breast cancer cells reprogram tumor-associated macrophages and promote triple-negative breast cancer progression by targeting Notch1 in macrophages. PubMed 41078903
- Tissue Cell, 2024 (senior author): Knockdown of NUF2-derived exosomes can inhibit the migration and autophagy of BC cells and improve resistance to doxorubicin. PubMed 38964084
- Photodiagnosis Photodyn Ther, 2022 (first author): Serum Raman spectroscopy combined with multiple classification models for rapid diagnosis of breast cancer. PubMed 36096439
- Medicine (Baltimore), 2021 (first author): Expression and prognosis analysis of GINS subunits in human breast cancer. PubMed 33725952
- Cancer Med, 2020 (first author): Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China. PubMed 33067872
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion